Details for New Drug Application (NDA): 016161
✉ Email this page to a colleague
NDA 016161 describes SYNALAR-HP, which is a drug marketed by Medimetriks Pharms and is included in one NDA. Additional details are available on the SYNALAR-HP profile page.
The generic ingredient in SYNALAR-HP is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
The generic ingredient in SYNALAR-HP is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
Summary for 016161
| Tradename: | SYNALAR-HP |
| Applicant: | Medimetriks Pharms |
| Ingredient: | fluocinolone acetonide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 016161
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 0.2% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
